🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety, tolerability and phar...
Status
Completed
Location
ATTN-Research Pharmacist
Start Date
2012-04-30
Trial ID
NCT01597193
Treatments Being Tested
The purpose of the study is to evaluate the efficacy of the triplet of rida...
Status
Completed
Location
Multiple Locations
Start Date
2012-07-04
Trial ID
NCT01605396
Treatments Being Tested
Primary Objective: To determine whether amcenestrant per overall survival ...
Status
Terminated
Location
Alabama Oncology - St. Vincent's Birmingham- Site Number : 8400008
Start Date
2019-10-22
Trial ID
NCT04059484
Treatments Being Tested
This international, multi-center, open-label, single-arm study evaluated th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-03-29
Trial ID
NCT03176238
Treatments Being Tested
The present multi-center, open-label, single-arm study aims to evaluate the...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-06
Trial ID
NCT01626222
Treatments Being Tested
The purpose of this study was to give access to postmenopausal women with e...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-03
Trial ID
NCT00649090
Treatments Being Tested
Men and post- or induced menopausal women with ER\[+\] and/or PgR\[+\], HER...
Status
Completed
Location
Hospital General Universitario de Alicante
Start Date
2020-10-23
Trial ID
NCT04300790
Treatments Being Tested
POLAR is a phase III clinical trial, which will test the safety and efficac...
Status
Active Not Recruiting
Location
Medizinische Universität Graz (MUG)
Start Date
2019-08-27
Trial ID
NCT03820830
Treatments Being Tested
The primary purpose of this study is to evaluate the tolerability and safet...
Status
Completed
Location
Eisai Trial Site 11
Start Date
2020-10-09
Trial ID
NCT04572295
Treatments Being Tested
The primary goal of this study is to evaluate the effectiveness of elacestr...
Status
Recruiting
Location
Southern Cancer Center, PC
Start Date
2024-09-27
Trial ID
NCT06492616
Treatments Being Tested